Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective

Journal Title: Istanbul Medical Journal - Year 2019, Vol 20, Issue 2

Abstract

Introduction: We aimed to investigate the levels of receptor activator of nuclear factor kappa-b ligand (RANKL) and osteoprotegerin (OPG) in order to evaluate the negative effects of type 2 diabetes mellitus on bone health and their relationship to the severity of disease based on the treatment. We also evaluated the relationship between hemoglobin A1c (HbA1c), parathyroid hormone (PTH) and bone specific alkaline phosphatase (BAP) levels and RANKL and OPG levels. Methods: The study group consisted of 19 volunteers (15 females and 4 males) and 65 patients with type 2 diabetes mellitus (49 females and 16 males). In order to evaluate the relationship between the treatment and the disease severity, the patient group was divided into two subgroups: patients treated with oral anti-diabetics (OAD) (sulfonylurea and metformin) or insulin. The levels of glucose, calcium, phosphorus, HbA1c, BAP, PTH, RANKL and OPG were compared. Results: The RANKL and OPG levels of patients treated with insulin were significantly higher than the control group (p=0.008, p=0.033, respectively). However, there was no significant difference in the OAD group for both parameters (p=0.1, p=0.46, respectively). There was no significant difference between the groups in terms of PTH and BAP levels (p=0.97, p=0.66, respectively). Conclusion: We believe that RANKL and OPG levels are higher in patients with poor glycemic control and that they may be indicators of disease severity.

Authors and Affiliations

Alper Gümüş, Muhammed Emin Düz, Cihan Coşkun, Mustafa Velet, Macit Koldaş

Keywords

Related Articles

Unexpected Histopathological Findings After Laparoscopic Sleeve Gastrectomy

Introduction: The prevalence of obesity is increasing all over the world. Laparoscopic sleeve gastrectomy (LSG) has become the most common bariatric surgery in the world today. Unlike other bariatric surgeries, laparosco...

Can VAP-1 Protein be used as a Biomarker in Thyroid Cancer?

Introduction: The aim of this study is to determine whether vascular adhesion protein-1 (VAP-1) glycoprotein can be used as a biomarker in thyroid cancer. Methods: Retrospective analysis of the pathology results of pati...

Is Component Separation a Safe Method in Incisional Hernias?

Introduction: Incisional hernias after abdominal surgical procedures cause morbidity, significant loss of labor and affect quality of life. In this study, we investigated whether component separation (CS) technique is a...

Baseline SUV Range for Liver and Blood Pool in Patients Undergoing F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

Introduction: The aim of the study was to define the baseline SUVmax range in the liver and blood pool of patients undergoing fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) imaging. Met...

The Role of Magnetic Resonance Imaging in the Differential Diagnosis of Giant Rectal and Perirectal Masses

Introduction: Our purpose was to depict some specific qualitative and quantitative magnetic resonance imaging (MRI) and diffusion weighted imaging (DWI) findings in differential diagnosis of huge tumors of rectum and per...

Download PDF file
  • EP ID EP549085
  • DOI 10.4274/imj.galenos.2018.04657
  • Views 189
  • Downloads 0

How To Cite

Alper Gümüş, Muhammed Emin Düz, Cihan Coşkun, Mustafa Velet, Macit Koldaş (2019). Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective. Istanbul Medical Journal, 20(2), -. https://europub.co.uk/articles/-A-549085